Share on StockTwits

MedAssets (NASDAQ:MDAS) Director Terrence J. Mulligan sold 1,000 shares of MedAssets stock on the open market in a transaction that occurred on Thursday, June 12th. The shares were sold at an average price of $23.30, for a total transaction of $23,300.00. Following the transaction, the director now directly owns 927 shares in the company, valued at approximately $21,599. The sale was disclosed in a document filed with the SEC, which is available at this link.

MDAS has been the subject of a number of recent research reports. Analysts at Citigroup Inc. downgraded shares of MedAssets from a “buy” rating to a “neutral” rating in a research note on Thursday, May 29th. They now have a $26.00 price target on the stock, down previously from $28.00. Separately, analysts at Bank of America downgraded shares of MedAssets from a “buy” rating to a “neutral” rating in a research note on Thursday, May 22nd. They now have a $24.00 price target on the stock, down previously from $25.00. Finally, analysts at Stephens initiated coverage on shares of MedAssets in a research note on Tuesday, May 20th. They set an “equal weight” rating and a $20.00 price target on the stock. Twelve research analysts have rated the stock with a hold rating and ten have assigned a buy rating to the company’s stock. MedAssets currently has a consensus rating of “Hold” and an average target price of $25.28.

Shares of MedAssets (NASDAQ:MDAS) traded up 0.13% on Tuesday, hitting $23.08. The stock had a trading volume of 129,715 shares. MedAssets has a one year low of $17.03 and a one year high of $26.58. The stock has a 50-day moving average of $23.17 and a 200-day moving average of $22.54. The company has a market cap of $1.408 billion and a P/E ratio of 52.39.

MedAssets (NASDAQ:MDAS) last issued its quarterly earnings data on Wednesday, April 30th. The company reported $0.32 earnings per share for the quarter, missing the analysts’ consensus estimate of $0.33 by $0.01. On average, analysts predict that MedAssets will post $1.37 earnings per share for the current fiscal year.

MedAssets, Inc (NASDAQ:MDAS) provides technology-enabled products and services.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.